Sun Pharmaceutical rises on reporting 14% surge in Q3 consolidated net profit
Sun Pharmaceutical Industries is currently trading at Rs. 1766.10, up by 23.40 points or 1.34% from its previous closing of Rs. 1742.70 on the BSE.
The scrip opened at Rs. 1775.00 and has touched a high and low of Rs. 1787.65 and Rs. 1735.70 respectively. So far 16921 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1960.20 on 30-Sep-2024 and a 52 week low of Rs. 1376.75 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 1822.15 and Rs. 1693.65 respectively. The current market cap of the company is Rs. 417004.42 crore.
The promoters holding in the company stood at 54.48%, while Institutions and Non-Institutions held 36.59% and 8.93% respectively.
Sun Pharmaceutical Industries has reported 63.74% rise in its net profit at Rs 1181.05 crore for Q3FY25 as compared to Rs 721.31 crore for the same quarter in the previous year. Total income of the company increased by 21.54% at Rs 6260.20 crore for Q3FY25 as compared to Rs 5150.55 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 13.61% rise in its net profit at Rs 2917.54 crore for the quarter ended December 31, 2024, as compared to Rs 2568.03 crore for the same quarter in the previous year. Total income of the company increased by 11.96% at Rs 14141.08 crore for Q3FY25 as compared to Rs 12630.90 crore for the corresponding quarter previous year.
